A Jan. 10 FDA warning letter
alleges St. Jude Medical Inc.’s committed quality system violations at the Sylmar, Calif. facility that produces Durata and Riata ST Optim implantable defibrillator leads.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?